Interpace Biosciences Statistics
Total Valuation
IDXG has a market cap or net worth of 2.96 million. The enterprise value is 7.36 million.
Market Cap | 2.96M |
Enterprise Value | 7.36M |
Important Dates
The last earnings date was Friday, April 11, 2025.
Earnings Date | Apr 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IDXG has 4.42 million shares outstanding. The number of shares has increased by 260.54% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.42M |
Shares Change (YoY) | +260.54% |
Shares Change (QoQ) | +1,024.21% |
Owned by Insiders (%) | 22.28% |
Owned by Institutions (%) | 3.25% |
Float | 3.44M |
Valuation Ratios
The trailing PE ratio is 1.63.
PE Ratio | 1.63 |
Forward PE | n/a |
PS Ratio | 0.06 |
PB Ratio | -1.34 |
P/TBV Ratio | n/a |
P/FCF Ratio | 0.79 |
P/OCF Ratio | 0.64 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.81, with an EV/FCF ratio of 1.95.
EV / Earnings | 1.18 |
EV / Sales | 0.16 |
EV / EBITDA | 0.81 |
EV / EBIT | 0.91 |
EV / FCF | 1.95 |
Financial Position
The company has a current ratio of 1.11
Current Ratio | 1.11 |
Quick Ratio | 0.94 |
Debt / Equity | n/a |
Debt / EBITDA | 0.64 |
Debt / FCF | 1.55 |
Interest Coverage | 12.30 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 36.32% |
Return on Invested Capital (ROIC) | 173.90% |
Return on Capital Employed (ROCE) | 194.11% |
Revenue Per Employee | 422,757 |
Profits Per Employee | 56,198 |
Employee Count | 111 |
Asset Turnover | 3.36 |
Inventory Turnover | 13.95 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.48% in the last 52 weeks. The beta is 0.69, so IDXG's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -52.48% |
50-Day Moving Average | 1.07 |
200-Day Moving Average | 1.73 |
Relative Strength Index (RSI) | 36.35 |
Average Volume (20 Days) | 15,176 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, IDXG had revenue of 46.93 million and earned 6.24 million in profits. Earnings per share was 0.39.
Revenue | 46.93M |
Gross Profit | 29.93M |
Operating Income | 8.11M |
Pretax Income | 6.95M |
Net Income | 6.24M |
EBITDA | 8.41M |
EBIT | 8.11M |
Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 1.46 million in cash and 5.86 million in debt, giving a net cash position of -4.40 million or -0.99 per share.
Cash & Cash Equivalents | 1.46M |
Total Debt | 5.86M |
Net Cash | -4.40M |
Net Cash Per Share | -0.99 |
Equity (Book Value) | -2.22M |
Book Value Per Share | -0.50 |
Working Capital | 1.16M |
Cash Flow
In the last 12 months, operating cash flow was 4.65 million and capital expenditures -876,000, giving a free cash flow of 3.77 million.
Operating Cash Flow | 4.65M |
Capital Expenditures | -876,000 |
Free Cash Flow | 3.77M |
FCF Per Share | 0.85 |
Margins
Gross margin is 63.77%, with operating and profit margins of 17.28% and 14.28%.
Gross Margin | 63.77% |
Operating Margin | 17.28% |
Pretax Margin | 14.81% |
Profit Margin | 14.28% |
EBITDA Margin | 17.92% |
EBIT Margin | 17.28% |
FCF Margin | 8.03% |
Dividends & Yields
IDXG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -260.54% |
Shareholder Yield | -260.54% |
Earnings Yield | 210.50% |
FCF Yield | 127.22% |
Stock Splits
The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.
Last Split Date | Jan 15, 2020 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
IDXG has an Altman Z-Score of -16.94. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -16.94 |
Piotroski F-Score | n/a |